Similarly, the distribution of Regulatory T cells showed an increasing trend in the groups treated with the drug (Supplementary Fig. 2f, g).
← all excerpts
Antitumor effects of immunotherapy combined with BRAF and MEK inhibitors in BRAF V600E metastatic colorectal cancer.
1
—
—